Table 1 Baseline characteristics of patients
Characteristic | Muscle training group (N = 109) | Control group (N = 112) | p | |
|---|---|---|---|---|
Age(years) | mean (range) | 51(20–66) | 52.5(18–68) | 0.068 |
Gender | Male | 78 | 76 | 0.549 |
Female | 31 | 36 | ||
BMI | mean (SD) | 23.04(3.33) | 23.23(3.33) | 0.666 |
Tumor site | Nasopharynx | 40(36.70) | 43(38.39) | 0.200 |
Sinonasal carcinoma | 3(2.75) | 12(10.71) | ||
Oral cavity | 32(29.36) | 23(20.53) | ||
Salivary gland | 14(12.84) | 15(13.39) | ||
Oropharynx | 10(9.17) | 12(10.71) | ||
Hypopharynx | 4(3.67) | 4(3.57) | ||
Others | 6(5.5) | 3(2.68) | ||
Oral stent | Yes | 53 | 40 | 0.052 |
No | 56 | 72 | ||
Surgery | Yes | 61 | 61 | 0.823 |
No | 48 | 51 | ||
Cervical curvature | 21.60(11.15) | 22.56(11.07) | 0.524 | |
Pre-treatment nutrition | mean (SD) | 3.00(2.43) | 2.84(2.00) | 0.592 |
Education | Primary and below | 13 | 24 | 0.066 |
Secondary | 55 | 59 | ||
Tertiary and above | 41 | 29 | ||
Treatment | RT | 52 | 60 | 0.383 |
CCRT | 27 | 30 | ||
IC + CCRT | 30 | 22 | ||
RT Volume(cm3) | mean (SD) | 601.89(150.92) | 592.98(147.32) | 0.788 |
T stage | N(%) | 0.596 | ||
T1 | 11(10.1) | 18(16.1) | ||
T2 | 33(30.3) | 27(24.1) | ||
T3 | 26(23.9) | 24(21.4) | ||
T4 | 38(34.9) | 41(36.6) | ||
Tx | 1(0.9) | 2(1.8) | ||
N stage | N(%) | 0.360 | ||
N0 | 42(38.5) | 35(31.3) | ||
N1 | 26(23.9) | 28(25.0) | ||
N2 | 32(29.4) | 42(37.5) | ||
N3 | 8(7.3) | 4(3.6) | ||
Nx | 1(0.9) | 3(2.7) | ||
M stage | N(%) | 0.834 | ||
M0 | 103(94.5) | 104(92.9) | ||
M1 | 4(3.7) | 6(5.4) | ||
Mx | 2(1.8) | 2(1.8) | ||
Offline ART | N(%) | 45(41.3) | 50(44.6) | 0.614 |